Aquestive Therapeutics
AQST
AQST
63 hedge funds and large institutions have $86.3M invested in Aquestive Therapeutics in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-2
Holders Change %
-3.08%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
18
Reduced
21
Closed
15
Calls
$902K
Puts
$1.17M
Net Calls
-$266K
Net Calls Change
+$337K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.68M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.21M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.08M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$720K |
| 5 |
IA
IndexIQ Advisors
New York
|
+$465K |
Top Sellers
| 1 |
BCM
Bratton Capital Management
Fort Worth,
Texas
|
-$8.8M |
| 2 |
PA
Perceptive Advisors
New York
|
-$7.41M |
| 3 |
Renaissance Technologies
New York
|
-$1.45M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.1M |
| 5 |
Nisa Investment Advisors
St. Louis,
Missouri
|
-$348K |
